Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India

Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India

vor 5 Jahren
11 Minuten
0
0 0 0

Beschreibung

vor 5 Jahren
It typically takes five years and about Rs 15 crore for just the
first of many phases to introduce a viable vaccine to market.
Companies across India such as Zydus Cadila, Serum Institute and
Bharat Biotech are working against the clock to shrink this period
down to a few months. In this episode Forbes Indias Divya Shekhar
takes a deep dive into what this rush looks like on the ground and
gives us a glimpse into the path ahead. Podcast produced in
association with theindicast.com
15
15
Close